北京生物医学工程

骨髓间充质干细胞干预治疗骨质疏松症中的骨组织生物力学性能

Biomechanical properties of bone tissue in the treatment of osteoporosis with bone marrow mesenchymal stem cells

作者：李云龙黄炳哲李正伟朴成东

单位：吉林大学第二医院（长春 130026）

关键词：骨质疏松动物模型；骨髓间充质干细胞；雷洛昔芬；骨密度；剪切；冲击；生物力学

分类号：R318.01

出版年·卷·期（页码）：2021·40·1（74-78）

摘要：

目的以雷洛昔芬干预治疗骨质疏松为对照，用生物力学性能指标验证骨髓间充质干细胞(bone mesenchymal stem cells ，BMSCs)干预治疗骨质疏松动物的效果。方法取6月龄雌性SD大鼠88只，随机分为骨质疏松动物模型组22只，正常对照组22只，雷洛昔芬干预组22只，骨髓间充质干细胞干预组22只。以摘除大鼠卵巢的方法建立骨质疏松动物模型。动物饲养4周后，分别以骨髓间充质干细胞和雷洛昔芬对骨质疏松动物进行干预治疗。于给药6周后检测各组大鼠血清Ca 、P 、碱性磷酸酶（alkaline phosphatase,ALP），并取胫骨进行剪切实验,取股骨进行冲击实验,测试肱骨的骨密度（bone mineral density，BMD）。结果骨髓间充质干细胞干预组肱骨BMD，血清Ca、ALP，胫骨各项剪切力学性能指标和股骨各项冲击力学性能指标大于模型组及雷洛昔芬干预组,其血清P小于模型组及雷洛昔芬干预组（P<0.05）。结论骨质疏松动物通过以骨髓间充质干细胞干预后，肱骨BMD，血清Ca、ALP，骨的强度和韧性可以得到一定恢复。

Taking raloxifene intervention in the treatment of osteoporosis as a control, biomechanical performance indicators are used to verify the effect of bone marrow mesenchymal stem cells (BMSCs) in the treatment of osteoporosis in animals. Methods 88 SD rats were randomly divided into 22 osteoporosis animal model group, 22 normal control group, 22 raloxifene intervention group, and 22 bone marrow mesenchymal stem cell intervention group. The osteoporosis animal model was established by removing the ovaries of rats. After the animals were raised for 4 weeks, bone marrow mesenchymal stem cells and raloxifene were used to intervene in osteoporotic animals. After 6 weeks of administration, the serum Ca, P, alkaline phosphatase (ALP) of each group of rats were measured, and tibia was taken for shearing experiment, femur was taken for impact experiment, and the bone mineral density (BMD) of humerus was tested. ). Results The humerus BMD, serum Ca, ALP, tibia and various impact mechanical performance indexes of the bone marrow mesenchymal stem cell intervention group were greater than those of the model group and the raloxifene intervention group, and the serum P was lower than the model group and Raloxifene intervention group (P<0.05). Conclusions After the intervention of bone marrow mesenchymal stem cells in osteoporotic animals, humerus BMD, serum Ca, ALP, bone strength and toughness can be restored to a certain extent.

参考文献：

[1] Kumar S, Wan C, Ramaswamy G, et al. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect[J]. Molecular Therapy，2010, 18(5): 1026-1034.

[2] Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects[J]. Journal of Clinical Investigation.2005，115(12):3318-3325.

[3] Cho SW, Sun HJ, Yang JY, et al. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4prevents bone loss in ovariectomized mice[J]. Molecular Therapy，2010,17(11):1979-1987.

［4］ Lazar A， Pacurar M， Campian R S． Bisphosphonates in bone diseases treatment［ J］． Revista De Chimie， 2017， 68 ( 2 ) :246-249．

[5] 李良,李冬菊,吴江.骨髓间充质干细胞在去卵巢大鼠骨质疏松发病机理中潜在的作用[J].生物医学工程学杂志2006,23(1):129-135.

Li L, Li D J, Wu J et al. A potential role for the bone marrow mesenchymal stem cellin the pathogenesis of osteoporosis by ovariectomy in rat[J]. Journal of Biomedical Engineering, 2006,23(1):129-135.

[6]张晖,程惊秋.瞬时干扰PPARγ基因促进酒精诱导下人骨髓基质干细胞成骨分化的实验研究[J].中华医学杂志,2008，88（37）：2603-2608.

Zhan H，Cheng J Q et al. Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma：an in vitro experiment study [J]. National Medical Journal of China, 2008，88（37）：2603-2608.

［7］ Shiraki M， Ueda S， Sugimoto T， et al． Treatment responses with once-weekly teriparatide therapy for osteoporosis［ J］.Osteoporosis International， 2016， 27( 10): 3057-3062．
［8］ Ummarino D．Osteoporosis: ramucirumab versus teriparatide［J］.Nat Rev Rheumatol， 2017， 13( 9):512-516.

[9]张泽华.BMSCs联合PTH治疗大鼠骨质疏松的实验研究[D].太原：山西医科大学，2019.

Zhang ZH. Experimental Study of BMSCs combined with PTH in the treatment of osteoporosis in rats[D]. Taiyuan：Shanxi Medical University,2019.

[10] Uejima S, Okada K, Kagami H, et al. Bone marrow stromal cell therapy improvesfemoralbonemineraldensityandmechanicalstrengthinovariectomizedrats[J]. Cytotherapy,2008,10(5):479-489.
[11] Piao CD, Li ZW, Ding J, et al. Bone viscoelastic properties in an animal model with osteoporosis after BMSC-alendronate sodium intervention[J]. Journal of Hard Tissue Biology，2019, 28（3）：315-320.

[12] Piao CD, Li ZW, Ding J, et al. Analysis of BMSCs-intervened viscoelasticity of sciatic nerve in rats with chronic alcoholic intoxication[J]. Acta Cirúrgica Brasileira, 2018, 33(10):935-944.

[13] Piao CD, Li ZW, Ding J, et al. Biomechanical analysis of poly lactic-co-glycolic acid catheter combined with bone marrow mesenchymal stem cells and extracellular matrix transplantation for long sciatic nerve defect repair[J]. Journal of Hard Tissue Biology ,2018，27(4):327-332.

[14] Piao CD, Li ZW, Ding J, et al.Comparative analysis of bone mechanical properties of adipose-derived mesenchymal stem cells and raloxifene in treatment of osteoporosis[J].Journal of Hard Tissue Biology, 2020, 29(2)： 71-76.

[15]刘忠厚.骨质疏松症〔M〕.北京:化学工业出版社, 1992: 138-139.

[16] 刘忠厚.骨质疏松症〔M〕.北京:科学出版社, 1998: 67-68.

[17] Griffith JF, Wang YX, Zhou H, et al. Reduced bone perfusionin osteoporosis: likely causes in an ovariectomy rat model[J]. Radiology， 2010，254（3）: 739-746.

[18] Lees S, Eyre DR, Barnard SM. BAPN dose dependence of mature crosslinking in bone matrix collagen of rabbit compact bone: corresponding variation of sonic velocity and equatorial diffraction spacing [J]. Connective Tissue Research,1990,24（1）:95–105.

[19] Wang Z, Goh J, Das DS, et al. Efficacy of bone marrow-Derived stem cells in strengthening osteoporotic bone in a rabbit model[J]. Tissue Engineering, 2006,48(12):1753-1761.

[20] Piao CD,Li ZW,Ding J，et al. Bone viscoelastic properties in an animal model with osteoporosis after BMSC-alendronate sodium intervention[J]. Journal of Hard Tissue Biology, 2019,28(3):315-320.

[21]Piao CD, Li ZW, Ding J，et al. Comparison of bone biomechanical properties after bone marrow mesenchymal stem cell or alendronate treatment in an osteoporotic animal model[J]. Biomedical Engineering-biomedizinische Technik,2019,64(6):721-727.

[22] Ocarino NM, Boeloni JN, Jorgetti V, et al. Intra-bonemarrow injection of mesenchymal stem cells improves thefemur bone mass of osteoporotic rats[J]. Connective Tissue Research,2010, 51(6): 426-433.

服务与反馈：

【文章下载】【加入收藏】

提示：您还未登录，请登录！点此登录